La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Souris And NotAudrey Hild

List of bibliographic references

Number of relevant bibliographic references: 84.
Ident.Authors (with country if any)Title
000038 D. M. Johnstone [Australie] ; N. El Massri [Australie] ; C. Moro [France] ; S. Spana [Australie] ; X. S. Wang [Australie] ; N. Torres [France] ; C. Chabrol [France] ; X. De Jaeger [France] ; F. Reinhart [France] ; S. Purushothuman [Australie] ; A.-L. Benabid [France] ; J. Stone [Australie] ; J. Mitrofanis [Australie]INDIRECT APPLICATION OF NEAR INFRARED LIGHT INDUCES NEUROPROTECTION IN A MOUSE MODEL OF PARKINSONISM - AN ABSCOPAL NEUROPROTECTIVE EFFECT
000173 WEI SONG [Canada] ; Hillel Zukor [Canada] ; Shih-Hsiung Lin [Canada] ; Adrienne Liberman [Canada] ; Ayda Tavitian [Canada] ; Jeannie Mui [Canada] ; Hojatollah Vali [Canada] ; Carine Fillebeen [Canada] ; Kostas Pantopoulos [Canada] ; Ting-Di Wu [France] ; Jean-Luc Guerquin-Kern [France] ; Hyman M. Schipper [Canada]Unregulated brain iron deposition in transgenic mice over-expressing HMOX1 in the astrocytic compartment
000311 Elaine Del-Bel [France] ; Fernando Eduardo Padovan-Neto [France] ; Rita Raisman-Vozarl [France] ; Marcio Lazzarini [France]Role of Nitric Oxide in Motor Control: Implications for Parkinson's Disease Pathophysiology and Treatment
000323 Benjamin Dehay [France] ; Erwan Bezard [France]New Animal Models of Parkinson's Disease
000346 Giselle Charron [France] ; Evelyne Doudnikoff [France] ; Alexis Laux [France] ; Amandine Berthet [France] ; Gregory Porras [France] ; Marie-Hélène Canron [France] ; Pedro Barroso-Chinea [France] ; QIN LI [République populaire de Chine] ; CHUAN QIN [République populaire de Chine] ; Marika Nosten-Bertrand [France] ; Bruno Giros [France] ; François Delalande [France] ; Alain Van Dorsselaer [France] ; Anne Vital [France] ; Yannick Goumon [France] ; Erwan Bezard [France, République populaire de Chine]Endogenous morphine-like compound immunoreactivity increases in parkinsonism
000359 Masahiro Shin [France] ; Caroline Jan [France] ; Carine Jacquard [France] ; Bechir Jarraya [France] ; Jacques Callebert [France] ; Jean-Marie Launay [France] ; Philippe Hantraye [France] ; Philippe Remy [France] ; Stephane Palfi [France] ; Emmanuel Brouillet [France]Chronic systemic treatment with a high-dose proteasome inhibitor in mice produces akinesia unrelated to nigrostriatal degeneration
000369 Erwan Bezard [France] ; Serge Przedborski [États-Unis]A Tale on Animal Models of Parkinson's Disease
000438 Sébastien Paillusson [France] ; Maddalena Tasselli [France] ; Thibaud Lebouvier [France] ; Maxime Michaël Mahe [France] ; Julien Chevalier [France] ; Mandy Biraud [France] ; Chystelle Cario-Toumaniantz [France] ; Michel Neunlist [France] ; Pascal Derkinderen [France]α-Synuclein expression is induced by depolarization and cyclic AMP in enteric neurons
000440 Fanny Schmiijt [France] ; Gael Le Douaron [France] ; Pierre Champy [France] ; Majid Amar [France] ; Blandine Seon-Meniel [France] ; Rita Raisman-Vozari [France] ; Bruno Figadere [France]Tryptamine-derived alkaloids from Annonaceae exerting neurotrophin-like properties on primary dopaminergic neurons
000441 Julie Deguil [France] ; François Chavant [France] ; Claire Lafay-Chebassier [France] ; Marie-Christine Perault-Pochat [France] ; Bernard Fauconneau [France] ; Stéphanie Pain [France]Time course of MPTP toxicity on translational control protein expression in mice brain
000488 Stephane Besnard [France] ; Michael Decressac [France] ; Pierre Denise [France]In-vivo deep brain recordings of intranigral grafted cells in a mouse model of Parkinson's disease
000517 Roberta Cavalcanti-Kwiatkoski [Brésil] ; Rita Raisman-Vozari [France] ; Laure Ginestet [France] ; Elaine Del Bel [Brésil]Altered expression of neuronal nitric oxide synthase in weaver mutant mice
000570 Serena Santucci [France] ; Nicole Zsiirger [France] ; Joëlle Chabry [France]β-N-methylamino-L-alanine induced in vivo retinal cell death
000607 Dario Cuomo [France, Italie] ; Giuseppina Martella [Italie] ; Emanuela Barabino [France] ; Paola Platania [Italie] ; Daniela Vita [Italie] ; Graziella Madeo [Italie] ; Chelliah Selvam [France] ; Cyril Goudet [France] ; Nadia Oueslati [France] ; Jean-Philippe Pin [France] ; Francine Acher [France] ; Antonio Pisani [Italie] ; Corinne Beurrier [France] ; Christophe Melon [France] ; Lydia Kerkerian-Le Goff [France] ; Paolo Gubellini [France]Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum : implications for Parkinson's disease treatment
000608 Elvira De Leonibus [Italie] ; Francesca Manago [Italie] ; Francesco Giordani [Italie] ; Francesco Petrosino [Italie] ; Sebastien Lopez [France] ; Alberto Oliverio [Italie] ; Marianne Amalric [France] ; Andrea Mele [Italie]Metabotropic Glutamate Receptors 5 Blockade Reverses Spatial Memory Deficits in a Mouse Model of Parkinson's Disease
000697 Jacques Epelbaum [France]Foxa2, une nouvelle piste neuro-développementale pour le Parkinson
000718 Anthony P. Nicholas [États-Unis] ; Farah D. Lubin [États-Unis] ; Penelope J. Hallett [États-Unis] ; Padmapriya Vattem [États-Unis] ; Paula Ravenscroft [Royaume-Uni] ; Erwan Bezard [France] ; SHAOBO ZHOU [Royaume-Uni] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada] ; J. David Sweatt [États-Unis] ; David G. Standaert [États-Unis]Striatal histone modifications in models of levodopa-induced dyskinesia
000737 Dieter Scheller [Allemagne] ; Christine Stichel-Gunkel [Allemagne] ; Hermann Lübbert [Allemagne] ; Gregory Porras [France] ; Paula Ravenscroft [Royaume-Uni] ; Michael Hill [Royaume-Uni] ; Erwan Bezard [France, Royaume-Uni]Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's disease
000745 Carine Chassain [France] ; Guy Bielicki [France] ; Elodie Durand [France] ; Stéphane Lolignier [France] ; Fatma Essafi [Tunisie] ; Amidou Traore [France] ; Franck Durif [France]Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse
000748 Charlotte Laloux [France] ; Philippe Derambure [France] ; Alexandre Kreisler [France] ; Elise Houdayer [France] ; Servane Brueziere [France] ; Régis Bordet [France] ; Alain Destée [France] ; Christelle Monaca [France]MPTP-treated mice : long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations
000760 Nathalie Thiriet [France] ; Lahouari Amar [France] ; Xauier Toussay [France] ; Virginie Lardeux [France] ; Bruce Ladenheim [États-Unis] ; Kevin G. Becker [États-Unis] ; Jean Lud Cadet [États-Unis] ; Marcello Solinas [France] ; Mohamed Jaber [France]Environmental enrichment during adolescence regulates gene expression in the striatum of mice
000777 A. Marighetto [France] ; S. Valerio [France] ; J. N. Philippin [France] ; V. Bertaina-Anglade [France] ; C. Drieu La Rochelle [France] ; R. Jaffard [France] ; P. Morain [France]Comparative effects of the dopaminergic agonists piribedil and bromocriptine in three different memory paradigms in rodents
000781 Daniel Alvarez-Fischer [Allemagne] ; Carmen Henze [Allemagne] ; Corinna Strenzke [Allemagne] ; Jan Westrich [Allemagne] ; Boris Ferger [Allemagne] ; Günter U. Höglinger [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Andreas Hartmann [Allemagne, France]Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and α-synuclein-deleted mice
000783 Marek Szatanik [France] ; Nicolas Vibert [France] ; Isabelle Vassias [France] ; Jean-Louis Guenet [France] ; Daniel Eugene [France] ; Catherine De Waele [France] ; Jean Jaubert [France]Behavioral effects of a deletion in Kcnn2, the gene encoding the SK2 subunit of small-conductance Ca2+-activated K+ channels
000803 Réunion conjointe de l'AFPB : Italie/Croatie/Grèce/Espagne, Marseille, 3 novembre 2005
000843 Charlotte Laloux [France] ; Philippe Derambure [France] ; Jean-Marie Jacquesson [France] ; Régis Bordet [France] ; Alain Destée [France] ; Christelle Monaca [France]The effects of serotoninergic, noradrenergic, cholinergic and dopaminergic drugs on vigilance states in MPTP-treated mice
000850 Elvira De Leonibus [Italie] ; Tiziana Pascucci [Italie] ; Sebastien Lopez [France] ; Alberto Oliverio [Italie] ; Marianne Amalric [France] ; Andrea Mele [Italie]Spatial deficits in a mouse model of Parkinson disease
000851 Elvira De Leonibus [Italie] ; Tiziana Pascucci [Italie] ; Sebastien Lopez [France] ; Alberto Oliverio [Italie] ; Marianne Amalric [France] ; Andrea Mele [Italie]Spatial deficits in a mouse model of Parkinson disease
000880 Alexandre Kreisler [France] ; Patrick Gele [France] ; Jean-Francois Wiart [France] ; Michel Lhermitte [France] ; Alain Destke [France] ; Régis Bordet [France]Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease : Fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not
000883 Emmanuelle Lagrue [France] ; Sylvie Chalon [France] ; Sylvie Bodard [France] ; Elie Saliba [France] ; Pierre Gressens [France] ; Pierre Castelnau [France]Lamotrigine is neuroprotective in the energy deficiency model of MPTP intoxicated mice
000918 Fabrice Guillemot [France] ; Italina Cerutti [France] ; Charles Auffray [France] ; Marie-Dominique Devignes [France]A transgenic mouse model engineered to investigate human brain-derived neurotrophic factor in vivo
000B00 Magali Periquet [France] ; Olga Corti [France] ; Sandrine Jacquier [France] ; Alexis Brice [France]Proteomic analysis of parkin knockout mice : alterations in energy metabolism, protein handling and synaptic function
000B14 Yan-Qin Shen [République populaire de Chine, France] ; Guillaume Hebert [France] ; Yun Su [France] ; Elizabeth Moze [France] ; Pierre J. Neveu [France] ; Kang-Sheng Li [République populaire de Chine]In mice, production of plasma IL-1 and IL-6 in response to MPTP is related to behavioral lateralization
000C18 Howard T. J. Mount [Canada] ; Jean-Claude Martel [France] ; Paul Fluit [Canada] ; YINGJI WU [Canada] ; Eleanor Gallo-Hendrikx [Canada] ; Cristina Cosi [France] ; Marc R. Marien [France]Progressive sensorimotor impairment is not associated with reduced dopamine and high energy phosphate donors in a model of ataxia-telangiectasia
000C29 P. O. Fernagut [France] ; E. Diguet [France] ; B. Bioulac [France] ; F. Tison [France]MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: eeference to striatonigral degeneration
000C68 Elsa Y. Pioli [France] ; Sandra Dovero [France] ; Bernard H. Bioulac [France] ; Christian E. Gross [France] ; Erwan Bezard [France]Asymmetrically lesioned mesencephalon in healthy rodents: call for caution
000D35 Guillaume Hebert [France] ; Josette Arsaut [France] ; Robert Dantzer [France] ; Jacques Demotes-Mainard [France]Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a dopaminergic neurotoxin
000D51 Christian E. Gross [France] ; Paula Ravenscroft [France] ; Sandra Dovero [France] ; Mohamed Jaber [France] ; Bernard Bioulac [France] ; Erwan Bezard [France]Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice
000D57 Jeffrey N. Joyce [États-Unis] ; Steve Presgraves [États-Unis] ; Lynn Renish [États-Unis] ; Sabinne Borwege [États-Unis] ; Tracy Osredkar [États-Unis] ; Diane Hagner [États-Unis] ; Maria Replogle [États-Unis] ; Mateo Pazsoldan [États-Unis] ; Mark J. Millan [France]Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole
000D60 Jose-Luis Gonzalez De Aguilar [France] ; Frédérique Rene [France] ; Luc Dupuis [France] ; Jean-Philippe Loeffler [France]Neuroendocrinology of neurodegenerative diseases: Insights from transgenic mouse models
000D99 Karine Parain [France] ; Céline Hapdey [France] ; Estelle Rousselet [France] ; Véronique Marchand [France] ; Bernard Dumery [France] ; Etienne C. Hirsch [France]Cigarette smoke and nicotine protect dopaminergic neurons against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinsonian toxin
000E09 Carine Cleren [France] ; Bertrand Naudin [France] ; Jean Costentin [France]Apparent opposite effects of tetrabenazine and reserpine on the toxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine on nigro-striatal dopaminergic neurons
000E89 Estelle Rousselet [France] ; Jacques Callebert [France] ; Karine Parain [France] ; Chantal Joubert [France] ; Stéphane Hunot [France] ; Andreas Hartmann [France] ; Claude Jacque [France] ; Fernando Perez-Diaz [France] ; Charles Cohen-Salmon [France] ; Jean-Marie Launay [France] ; Etienne C. Hirsch [France]Role of TNF-α receptors in mice intoxicated with the parkinsonian toxin MPTP
000E95 T. Breidert [France] ; J. Callebert [France] ; M. T. Heneka [Allemagne] ; G. Landreth [États-Unis] ; J. M. Launay [France] ; E. C. Hirsch [France]Protective action of the peroxisome proliferator-activated receptor-γ agonist pioglitazone in a mouse model of Parkinson's disease
000F24 Samuel G. Speciale [États-Unis]MPTP: Insights into parkinsonian neurodegeneration
000F44 Aïcha Douhou [France] ; Thomas Debeir [France] ; Mario Gustavo Murer [Argentine] ; Louis Do [France] ; Noëlle Dufour [France] ; Véronique Blanchard [France] ; Saliha Moussaoui [France] ; Georg Andrees Bohme [France] ; Yves Agid [France] ; Rita Raisman-Vozari [France]Effect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice
000F51 Diego Centonze [Italie] ; Alessandro Usiello [France] ; Paolo Gubellini [Italie] ; Antonio Pisani [Italie] ; Emiliana Borrelli [France] ; Giorgio Bernardi [Italie] ; Paolo Calabresi [Italie]Dopamine D2 receptor-mediated inhibition of dopaminergic neurons in mice lacking D2L receptors
000F62 Marion Blin [France] ; Wim E. Crusio [États-Unis] ; Tobias Hevor [France] ; Jean-Francois Cloix [France]Chronic inhibition of glutamine synthetase is not associated with impairment of learning and memory in mice
000F73 A. Nicotra [Italie] ; S. H. Parvez [France]Apoptotic molecules and MPTP-induced cell death
000F82 EFFETS D'UNE DEPOLARISATION CHRONIQUE SUR LE DEVELOPPEMENT ET LA SURVIE DES NEURONES DOPAMINERGIQUES DU MESENCEPHALE : MODULATION PAR DES ANTAGONISTES DE LA TRANSMISSION GLUTAMATERGIQUE
001043 Karine Parain [France] ; Véronique Marchand [France] ; Bernard Dumery [France] ; Etienne Hirsch [France]Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice
001087 Hélène Turmel [France] ; Andreas Hartmann [France] ; Karine Parain [France] ; Aicha Doubou [France] ; Anu Srinivasan [États-Unis] ; Yves Agid [France] ; Etienne C. Hirsch [France]Caspase-3 activation in 1 -methyl-4-phenyl- 1, 2,3,6-tetrahydropyridine (MPTP)-treated mice
001175 A. Boireau [France] ; P. Dubedat [France] ; F. Bordier [France] ; A. Imperato [France] ; S. Moussaoui [France]The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP+ accumulation
001177 M. G. Murer [France, Argentine] ; G. Dziewczapolski [Argentine] ; P. Salin [France] ; M. Vila [France] ; K. Y. Tseng [Argentine] ; M. Ruberg [France] ; M. Rubinstein [Argentine] ; M. A. Kelly [États-Unis] ; D. K. Grandy [États-Unis] ; M. J. Low [États-Unis] ; E. Hirsch [France] ; R. Raisman-Vozari [France] ; O. Gershanik [Argentine]The indirect basal ganglia pathway in dopamine D2 receptor-deficient mice
001188 M. Grandbois [Canada] ; M. Morissette [Canada] ; S. Callier [Canada, France] ; T. Di Paolo [Canada]Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice
001190 Patrice Mayer [France] ; Pascale Brunel [France] ; Céline Chaplain [France] ; Christel Piedecoq [France] ; Francis Calmel [France] ; Philippe Schambel [France] ; Philippe Chopin [France] ; Thierry Wurch [France] ; Petrus J. Pauwels [France] ; Marc Marien [France] ; Jean-Louis Vidaluc [France] ; Thierry Imbert [France]New substituted 1-(2,3-dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl derivatives with α2-Adrenoceptor antagonist activity
001242 D. C. Rogers [Royaume-Uni] ; B. Costall [Royaume-Uni] ; A. M. Domeney [France] ; P. A. Gerrard [Royaume-Uni] ; M. Greener [Royaume-Uni] ; M. E. Kelly [Royaume-Uni] ; J. J. Hagan [Royaume-Uni] ; A. J. Hunter [Royaume-Uni]Anxiolytic profile of ropinirole in the rat, mouse and common marmoset
001315 M. Merad-Saïdoune [France] ; E. Boitier [France] ; A. Nicole [France] ; C. Marsac [France] ; J. C. Martinou [Suisse] ; B. Sola [France] ; P.-M. Sinet [France] ; I. Ceballos-Picot [France]Overproduction of Cu/Zn-superoxide dismutase or Bcl-2 prevents the brain mitochondrial respiratory dysfunction induced by glutathione depletion
001328 C. Fillebeen [France] ; V. Mitchell [France] ; D. Dexter [Royaume-Uni] ; M. Benaissa [France] ; J.-C. Beauvillain [France] ; G. Spik [France] ; A. Pierce [France]Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment
001368 E. Bezard [France] ; C. E. Gross [France] ; M.-C. Fournier [France] ; S. Dovero [France] ; B. Bloch [France] ; M. Jaber [France]Absence of MPTP-lnduced neuronal death in mice lacking the dopamine transporter
001413 P. Emond [France] ; L. Farde [Suède] ; S. Chalon [France] ; C. Belzung [France] ; V. Mauclaire [France] ; J. P. Chiron [France] ; C. Halldin [Suède] ; C. Besnard [France] ; D. Guilloteau [France]Toxicity, mutagenicity, and behavioral effects of β-CIT, a ligand for dopamine transporter exploration by SPECT
001414 E. Bezard [France] ; T. Boraud [France] ; C. Imbert [France] ; S. Dovero [France] ; B. Bioulac [France] ; C. E. Gross [France]Towards a dynamic approach of experimental parkinsonism
001428 A. Boireau [France] ; M. Meunier [France] ; A. Imperato [France]Ouabain-induced increase in dopamine release from mouse striatal slices is antagonized by riluzole
001444 W. Krezel [France] ; N. Ghyselinck [France] ; T. A. Samad [France] ; V. Dupe [France] ; P. Kastner [France] ; E. Borrelli [France] ; P. Chambon [France]Impaired locomotion and dopamine signaling in retinoid receptor mutant mice
001458 A. Nicole [France] ; D. Santiard-Baron [France] ; I. Ceballos-Picot [France]Direct evidence for glutathione as mediator of apoptosis in neuronal cells : Dossier "Apoptosis Part II"
001467 N. Aubin [France] ; O. Curet [France] ; A. Deffois [France] ; C. Carter [France]Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice
001478 Effet de la mutation weaver sur la dégénérescence des neurones dopaminergiques du mésencéphale ventral : analyse de l'expression du transporteur membranaire de la dopamine et d'un canal potassique couplé à une protéine G
001548 A. Boireau [France] ; F. Bordier [France] ; P. Dubedat [France] ; C. Peny [France] ; A. Imperato [France]Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice
001568 N. B. Mercuri [Italie] ; A. Saiardi [France] ; A. Bonci [Italie] ; R. Picetti [France] ; P. Calabresi [Italie] ; G. Bernardi [Italie] ; E. Borrelli [France]Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice
001569 E. Bezard [France] ; S. Dovero [France] ; B. Bioulac [France] ; C. E. Gross [France]Kinetics of nigral degeneration in a chronic model of MPTP-treated mice
001580 L. J. Anghileri [France] ; P. Thouvenot [France] ; A. Bertrand [France]Effects of iron complexes on brain calcium homeostasis
001581 E. Bezard [France] ; S. Dovero [France] ; B. Bioulac [France] ; C. Gross [France]Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice
001595 C. Adelbrecht [France] ; M. G. Murer [France] ; I. Lauritzen [France] ; F. Lesage [France] ; M. Ladzunski [France] ; Yves Agid [France] ; R. Raisman-Vozari [France]An immunocytochemical study of a G-protein-gated inward rectifier K+ channel (GIRK2) in the weaver mouse mesencephalon
001655 C. Adelbrecht [France] ; Yves Agid [France] ; R. Raisman-Vozari [France]Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental area
001674 Analyse moléculaire et cellulaire de la mutation weaver de la souris
001713 JA-HYUN BAIK [France] ; R. Picetti [France] ; A. Saiardi [France] ; G. Thiriet [France] ; A. Dierich [France] ; A. Depaulis [France] ; M. Le Meur [France] ; E. Borrelli [France]Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors
001720 A. Boireau [France] ; F. Bordier ; P. Dubedat ; A. DobleMethamphetamine and dopamine neurotoxicity : differential effects of agents interfering with glutamatergic transmission
001742 B. Naudin [France] ; J.-J. Bonnet ; J. CostentinAcute L-DOPA pretreatment potentiates 6-hydroxydopamine-induced toxic effects on nigro-striatal dopamine neurons in mice
001784 P. Gaspar [France] ; N. B. Jelloun ; A. FebvretSparing of the dopaminergic neurons containing calbindin-D28k and of the dopaminergic mesocortical projections in weaver mutant mice
001787 A. Boireau [France] ; P. Dubedat ; F. Bordier ; C. Peny ; J.-M. Miquet ; G. Durand ; M. Meunier ; A. DobleRiluzole and experimental parkinsonism : antagonism of MPTP-induced decrease in central dopamine levels in mice
001818 Caractérisation moléculaire de récepteurs dopaminergiques murins de sous-type D2 et de leur mécanisme de transduction du signal
001859 I. Marey-Semper [France] ; M. Gelman ; M. Levi-StraussThe high sensitivity to rotenone of striatal dopamine uptake suggests the existence of a constitutive metabolic deficiency in dopaminergic neurons from the substantia nigra
001957 L. J. Anghileri [France]Effects of complexes iron and aluminium on brain calcium
001A94 G. Renoux ; K. Biziere ; M. Renoux ; R. Steinberg ; J.-P. Kan ; J.-M. GuillauminSodium diethyldithiocarbamate protects against the MPTP-induced inhibition of immune responses in mice

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024